Result of AGM

GlaxoSmithKline PLC
17 May 2006

Issued - Wednesday 17 May 2006, London - LSE Announcement





GlaxoSmithKline plc - Results of AGM



GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all
resolutions, including those electing and re-electing Board members, were passed 
by shareholders.



GlaxoSmithKline Annual General Meeting Poll Results



The following table shows the votes cast for each resolution:


    Resolution      Total votes for*     %         Total votes      %      Total votes     Abstentions**
                                                     against                  cast
 1  Adoption of      3,855,039,326     94.59       220,367,300     5.41   4,075,406,626     101,966,993
    Financial
    Statements
 2  Approval of the  3,813,702,842     92.25       320,348,275     7.75   4,134,051,117      43,322,502
    Remuneration
    Report
 3  Election of Dr   4,104,069,659     99.29       29,389,909      0.71   4,133,459,568      43,914,051
    Moncef Slaoui
 4  Election of Tom  4,152,473,410     99.67       13,811,481      0.33   4,166,284,891      11,088,728
    de Swaan
 5  Re-election of   4,139,769,880     99.36       26,761,365      0.64   4,166,531,245      10,842,374
    Larry Culp
 6  Re-election of   4,139,913,421     99.36       26,702,005      0.64   4,166,615,426      10,758,193
    Sir Crispin
    Davis
 7  Re-election of   4,130,055,407     99.12       36,639,628      0.88   4,166,695,035      10,678,584
    Dr Ronaldo
    Schmitz
 8  Re-appointment   4,105,860,589     99.36       26,520,893      0.64   4,132,381,482      44,992,137
    of Auditors
 9  Remuneration of  4,145,609,945     99.48       21,844,882      0.52   4,167,454,827      9,918,792
    Auditors
10  To authorise     4,081,281,019     98.11       78,621,700      1.89   4,159,902,719      17,470,900
    the company to
    make
    donations to EU
    Political
    Organisations &
    incur EU
    Political
    Expenditure
11  Authority to     4,080,970,037     97.99       83,853,325      2.01   4,164,823,362      12,550,257
    allot shares
12  Disapplication   4,132,232,501     99.10       37,630,848      0.90   4,169,863,349      7,510,270
    of pre-emption
    rights***
13  Authority for    4,151,078,987     99.61       16,151,515      0.39   4,167,230,502      10,143,117
    the Company to
    purchase its
    own shares***





Notes:

*      Includes discretionary votes.

**     An abstention is not a vote in law and is not counted in the calculation
       of the proportion of votes "For" or "Against" a resolution.

***    Indicates Special Resolutions requiring a 75% majority



The following table provides further relevant information:




                                                 GlaxoSmithKline's      GlaxoSmithKline's

                                                   Sixth AGM (2006)       Fifth AGM (2005)


Issued share capital                                  5,820,406,967         5,852,415,354

(excluding Treasury Shares)


Total votes cast and abstentions lodged as                   71.77%                70.56%
a % of GSK's issued share capital
(excluding Treasury Shares).


Total shareholder population.                               192,331               209,029


Total number of proxies lodged.                              15,907                16,156


% of shareholders who lodged proxies.                         8.27%                 7.73%


Number of shareholders,  corporate                              290                   286
representatives and proxies who attended
the AGM





S M Bicknell

Company Secretary

17 May 2006



These results will shortly be available on the Company's website www.gsk.com.




Enquiries:         UK Media                         Philip Thomson        [phone]

                                                    Gwenan Evans          [phone]

                                                    Alice Hunt            [phone]

                   US Media                         Nancy Pekarek         [phone]

                                                    Mary Anne Rhyne       [phone]

                                                    Patricia Seif         [phone]

                   European Analyst / Investor      Duncan Learmouth      [phone]

                                                    Anita Kidgell         [phone]

                                                    Jen Hill              [phone]

                                                    David Mawdsley        [phone]

                   US Analyst / Investor            Frank Murdolo         [phone]

                                                    Tom Curry             [phone]






                      This information is provided by RNS
            The company news service from the London Stock Exchange